Nicosia, Cyprus. The Cyprus addiction treatment authority said it is stepping up harm reduction policies as new synthetic opioids, polydrug use and widening inequalities increase drug-related risks.
Statement on International Harm Reduction Day
In a statement marking International Harm Reduction Day on May 7, the authority’s president, Christos Minas, said harm reduction is a key part of modern drug policy, focusing on health, dignity and saving lives.
Rising and more complex drug threats in Europe
Minas said data from the European Union’s drugs agency show Europe is facing more complex drug threats, including highly potent new substances. He said early intervention, overdose prevention and action against infectious disease remain urgent public health priorities.
Evidence-based measures and expanded access
Minas said harm reduction is an evidence-based approach that reduces deaths and improves health outcomes. He cited measures including clean syringe distribution, opioid agonist treatment, wider access to naloxone to reverse opioid overdoses, and outreach programmes.
Service expansion in Cyprus and focus on vulnerable groups
Minas said the authority is expanding services and improving their quality, with a stronger focus on vulnerable groups. He added that efforts are being reinforced in correctional institutions, where access to treatment and support is often more limited.
Plans for integrated care and better coordination
He said future efforts include developing integrated “one-stop shop” care centres and improving coordination between health services, social care and community organisations, with the aim of creating a more connected and accessible system of support.
What harm reduction services would you like to see prioritised in your community?